SCHEMBL5042882

SCHEMBL5042882

CCOC(=O)C(OCC)c1c(F)cc(Oc2ccc(OC)cc2)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.41
KMT2A Q03164 3/20 0.41
GAA P10253 1/20 0.41
GLA P06280 1/20 0.39
PRKCZ Q05513 1/20 0.39
HPGD P15428 3/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
S1PR2 O95136 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
PARP10 Q53GL7 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5042607 0.89 CYP3A4 (0.40) KMT2AGAAGLAPRKCZHPGD
SCHEMBL5047314 0.89 MAPK1 (0.47) NPC1ALDH1A1L3MBTL1TSHRMAPK1
SCHEMBL5041275 0.88 LDHA (0.40) PTGS2HPGDPARP10
SCHEMBL5042724 0.88 HIF1A (0.38) KMT2AGAAHPGDALDH1A1MAPK1
SCHEMBL5043292 0.85 S1PR2 (0.41) KMT2AGAARAB9AS1PR2PARP10
SCHEMBL5040727 0.80 PRKCZ (0.44) KMT2AGAAGLAPRKCZHPGD
SCHEMBL5040728 0.80 PRKCZ (0.44) KMT2AGAAGLAPRKCZHPGD
SCHEMBL5042114 0.79 ELANE (0.38)
SCHEMBL5042392 0.78 CA12 (0.42) GAAHPGDTDP1
SCHEMBL5040650 0.78 AKR1C3 (0.46) ALDH1A1L3MBTL1TSHRMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PTGS2 3734/4885KMT2A 1963/4885GAA 1312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.